Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/203866
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms

AutorVázquez-Borrego, Mari C.; Fuentes-Fayos, Antonio C.; Herrera-Martínez, Aura D.; López, Fernando L.; Ibáñez-Costa, Alejandro; Moreno-Moreno, Paloma; Alhambra-Expósito, María R.; Barrera-Martín, Ana; Blanco-Acevedo, Cristóbal; Dios Fuentes, Elena CSIC; Venegas Moreno, Eva CSIC; Solivera, Juan; Gahete, Manuel D.; Soto-Moreno, Alfonso CSIC ORCID; Gálvez-Moreno, María Ángeles; Castaño, Justo P.; Luque, Raúl M.
Fecha de publicaciónago-2019
EditorOxford University Press
CitaciónJournal of Clinical Endocrinology and Metabolism 104(8): 3501-3513 (2019)
Resumen[Context] Pituitary neuroendocrine tumors (PitNETs) are a commonly underestimated pathology in terms of incidence and associated morbimortality. Currently, an appreciable subset of patients are resistant or poorly responsive to the main current medical treatments [i.e., synthetic somatostatin analogs (SSAs) and dopamine agonists]. Thus, development and optimization of novel and available medical therapies is necessary. Biguanides (metformin, buformin, and phenformin) are antidiabetic drugs that exert antitumoral actions in several tumor types, but their pharmacological effects on PitNETs are poorly known.
[Objective] We aimed to explore the direct effects of biguanides on key functions (cell viability, hormone release, apoptosis, and signaling pathways) in primary cell cultures from human PitNETs and cell lines. Additionally, we evaluated the effect of combined metformin with SSAs on cell viability and hormone secretion.
[Design] A total of 13 corticotropinomas, 13 somatotropinomas, 13 nonfunctioning PitNETs, 3 prolactinomas, and 2 tumoral pituitary cell lines (AtT-20 and GH3) were used to evaluate the direct effects of biguanides on cell viability, hormone release, apoptosis, and signaling pathways.
[Results] Biguanides reduced cell viability in all PitNETs and cell lines (with phenformin being the most effective biguanide) and increased apoptosis in somatotropinomas. Moreover, buformin and phenformin, but not metformin, reduced hormone secretion in a cell type–specific manner. Combination metformin/SSA therapy did not increase SSA monotherapy effectiveness. Effects of biguanides on PitNETs could involve the modulation of AMP-activated protein kinase–dependent ([Ca2+]i, PI3K/Akt) and independent (MAPK) mechanisms.
[Conclusion] Altogether, our data unveil clear antitumoral effects of biguanides on PitNET cells, opening avenues to explore their potential as drugs to treat these pathologies.
Versión del editorhttps://doi.org/10.1210/jc.2019-00056
URIhttp://hdl.handle.net/10261/203866
DOI10.1210/jc.2019-00056
ISSN0021-972X
E-ISSN1945-7197
Aparece en las colecciones: (IBIS) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf59,24 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

28
checked on 24-mar-2024

WEB OF SCIENCETM
Citations

27
checked on 23-feb-2024

Page view(s)

165
checked on 29-mar-2024

Download(s)

19
checked on 29-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.